$PODD 4/A SEC Filings

Filed On	Filing
07 Jul 2026	Form 4/A: Huffines Robert Luther, Director Received 151 shares as a grant or award ($23K)
04 Mar 2022	Form 4/A: Petrovic Shacey, Director Received 6,347 shares as a grant or award · Granted 17,473 Employee Stock Option (Right to Buy)
05 Mar 2019	Form 4/A: Benjamin Eric, SVP, R&D, New Prod Dev. & Comm Received 1,154 shares as a grant or award · Granted 3,001 Employee Stock Option (Right to Buy)
17 Dec 2014	Form 4/A: Sullivan Patrick J, Director Granted 499,468 Employee Stock Option (Right to Buy)
02 Nov 2012	Form 4/A: Lortz W Mark, Director Granted 25,000 Stock Option (Right to Buy)
04 Apr 2012	Form 4/A: DeSisto Duane, Director Received 70,000 shares as a grant or award · Granted 70,000 Employee Stock Option (Right to Buy) · Received 20,000 shares by exercise or conversion ($52.5K) · 1 more
17 Feb 2012	Form 4/A: DePietro Ruthann, Vice President of Quality Received 1,000 shares by exercise or conversion ($5.94K) · Sold 1,000 shares ($19.6K) · Received 3,000 shares by exercise or conversion ($17.8K) · 1 more
17 Feb 2012	Form 4/A: DePietro Ruthann, Vice President of Quality Received 9,000 shares by exercise or conversion ($53.5K) · Sold 10,819 shares ($217K)
03 Feb 2009	Form 4/A: Campbell Robert, Vice President for Clinical Bought 1,000 shares ($4.4K)
03 Feb 2009	Form 4/A: Campbell Robert, Vice President for Clinical Bought 6,000 shares ($21.5K)
03 Dec 2008	Form 4/A: Campbell Robert, Vice President for Clinical Bought 1,000 shares ($4.4K)
21 Oct 2008	Form 4/A: Campbell Robert, Vice President for Clinical Received 7,918 shares by exercise or conversion ($22.5K)
07 Feb 2008	Form 4/A: Nye Gordon E, Director Holds 0 shares of No securities are beneficiallly owned

Comments